ArticleFrontiers in immunology2024
Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response.
Yanping Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it